newcleo books roughly €10M quarterly sales and holds €233M cash as prototype core completes
The Nasdaq-listed nuclear developer reports preliminary third-quarter numbers, a finished core at its Italian test unit, two industrial moves and a favourable French regulatory view.
newcleo (Nasdaq: NWCL), which develops nuclear reactors and mixed-oxide (MOX) fuel, put out preliminary third-quarter figures on 18 November. Sales from its products and services came to about €10.0M, which the company says is 26% higher. It did not provide the comparison figure in the material we reviewed. Cash on 30 September was €233.4M.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on CompePharma and VigiEye
- One subscription for both sites, cancel any time
Company's press release (SEC filing): newcleo plc ↗
Written by CompePharma's editorial system from the company's filing; claims are the company's. AI-assisted; check the source before acting. Not investment advice.